Categories

2022-2023 EVENTS



2022 Events

28 Aug - 01 Sep 2022
The International Surgical Week (ISW)
Kuala Lumpur

31 Aug – 2 Sept 2022
Medical Fair Asia
Marina Bay Sands, Singapore

3-9 September
Medical Fair Asia
Digital, Online

9-10 September 2022
World Pediatrics Conference
Bangkok, Thailand

9-10 September 2022
World Heart and Cardiothoracic Surgery Conference
Bangkok, Thailand

19-21 September 2022
23rd SE-Asian Healthcare & Pharma Show
Kuala Lumpur

27-29 September 2022
Smart Healthcare Expo (Health Malaysia)
MITEC

27-29 September 2022
Asia Pandemic Congress
Kuala Lumpur Convention Centre

19-20 September 2022
23nd Global Nursing Education Conference
Brisbane, Australia

30 Sep - 2 Oct 2022
Malaysia International Dental Show (MIDS)
Sunway Pyramid Convention Centre, Subang Jaya, Malaysia

7-9 November 2022
Saudi International MedLab Expo
Riyadh International Convention and Exhibition Center

7-9 November 2022
Saudi International Pharma Expo
Riyadh International Convention and Exhibition Center

11-13 November 2022
Eldercare Exhibition and Conference Asia (ELDEX Asia 2022)
Suntex Singapore Exhibition and Convention Centre

14-15 November 2022
Healthcare Asia Pacific
Osaka, Japan

2023 Events

30 May – 1 June 2023
APHM
KL Convention Centre, Kuala Lumpur

13-15 September 2023
Medical Fair Thailand
BITEC, Bangkok


Free counters!

CanSino's COVID-19 vaccine approved as booster shot

CanSino’s single-dose Convidecia vaccine has obtained conditional approval as a booster shot from Malaysia’s Drug Control Authority (DCA), which is under the National Pharmaceutical Regulatory Agency (NPRA).

Solution Group Bhd, via subsidiary Solution Biologics Sdn Bhd, said the DCA has consented to  Convidecia being used as a booster.
Convidecia is an adenovirus type-5 vector-based vaccine.

Mjn E-news
CanSino’s COVID-19 vaccine approved as booster shot
CanSino's - CanSinos

CanSino’s

CanSino’s single-dose Convidecia vaccine has obtained conditional approval as a booster shot from Malaysia’s Drug Control Authority (DCA), which is under the National Pharmaceutical Regulatory Agency (NPRA).

Solution Group Bhd, via subsidiary Solution Biologics Sdn Bhd, said the DCA has consented to  Convidecia being used as a booster. Convidecia is an adenovirus type-5 vector-based vaccine.

The approval “allows” the CanSino vaccine to be used on those aged 18 and above, three to six months after their first dose of the CanSino vaccine, a press statement from the group said.

Deputy group managing director Datuk Mohd Nazlee Kamal said studies showed that Convidecia’s single-dose vaccine is effective as a booster against the spread of COVID-19 variants. It demonstrated an increase of at least eight times higher neutralising antibody levels, six months after receiving the first dose.

“With this approval, we hope that it will help to increase the number of booster doses administered within the nation to stem the spread,” he said.

The group is also working towards getting NPRA approval for Convidecia to be used as a booster for other primary vaccine recipients such as CoronoVac, which is also known as Sinovac.

Solution Biologics delivered 3.5 million doses of the COVID-19 vaccine to the Ministry of Health in December 2021. Local production from its fill-and-finish facility is expected to start soon. – Bernama